Piracetam added to risperidone in patients with autistic disorder: a double-blind placebo controlled trial

被引：0
|
作者：
Akhondzadeh, Shahin [1 ]
Tajdar, Hamid [1 ]
Mohammadi, Mohammad-Reza [1 ]
Kashani, Ladan [1 ]
机构：
[1] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Psychiat Res Ctr, Tehran, Iran
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 63卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：777 / 777
页数：1
相关论文
共 50 条
  • [1] A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder
    Akhondzadeh, Shahin
    Tajdar, Hamid
    Mohammadi, Mohammad-Reza
    Mohammadi, Mohammad
    Nouroozinejad, Gholam-Hossein
    Shabstari, Omid L.
    Ghelichnia, Hossein-Ali
    [J]. CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2008, 39 (03) : 237 - 245
  • [2] A Double-blind Placebo Controlled Trial of Piracetam Added to Risperidone in Patients with Autistic Disorder
    Shahin Akhondzadeh
    Hamid Tajdar
    Mohammad-Reza Mohammadi
    Mohammad Mohammadi
    Gholam-Hossein Nouroozinejad
    Omid L. Shabstari
    Hossein-Ali Ghelichnia
    [J]. Child Psychiatry and Human Development, 2008, 39 : 237 - 245
  • [3] A double-blind placebo-controlled trial of risperidone in autistic disorder
    McDougle, C
    Aman, MG
    McCracken, JT
    Scahill, L
    Tierney, E
    Vitiello, B
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S327 - S328
  • [4] A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders
    Elmira Hasanzadeh
    Mohammad-Reza Mohammadi
    Ahmad Ghanizadeh
    Shams-Ali Rezazadeh
    Mina Tabrizi
    Farzin Rezaei
    Shahin Akhondzadeh
    [J]. Child Psychiatry & Human Development, 2012, 43 : 674 - 682
  • [5] A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders
    Hasanzadeh, Elmira
    Mohammadi, Mohammad-Reza
    Ghanizadeh, Ahmad
    Rezazadeh, Shams-Ali
    Tabrizi, Mina
    Rezaei, Farzin
    Akhondzadeh, Shahin
    [J]. CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2012, 43 (05) : 674 - 682
  • [6] A double-blind, placebo-controlled trial of risperidone in children with autistic disorder
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 458A - 458A
  • [7] Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder
    Rezaei, Vala
    Mohammadi, Mohammad-Reza
    Ghanizadeh, Ahmad
    Sahraian, Ali
    Tabrizi, Mina
    Rezazadeh, Shams-Ali
    Akhondzadeh, Shahin
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (07): : 1269 - 1272
  • [8] Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Ghaleiha, Ali
    Asadabadi, Mahtab
    Mohammadi, Mohammad-Reza
    Shahei, Maryam
    Tabrizi, Mina
    Hajiaghaee, Reza
    Hassanzadeh, Elmira
    Akhondzadeh, Shahin
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (04): : 783 - 789
  • [9] Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial
    Ghaleiha, Ali
    Alikhani, Rosa
    Kazemi, Mohammad-Reza
    Mohammadi, Mohammad-Reza
    Mohammadinejad, Payam
    Zeinoddini, Atefeh
    Hamedi, Mehdi
    Shahriari, Mona
    Keshavarzi, Zahra
    Akhondzadeh, Shahin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (09) : 784 - +
  • [10] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Mahtab Asadabadi
    Mohammad-Reza Mohammadi
    Ahmad Ghanizadeh
    Amirhossein Modabbernia
    Mandana Ashrafi
    Elmira Hassanzadeh
    Saeedeh Forghani
    Shahin Akhondzadeh
    [J]. Psychopharmacology, 2013, 225 : 51 - 59
12345